The effects of thymoquinone on pancreatic cancer and immune cells

Detalhes bibliográficos
Autor(a) principal: Alandağ,Celal
Data de Publicação: 2022
Outros Autores: Kancaği,Derya Dilek, Karakuş Sir,Gözde, Çakirsoy,Didem, Ovali,Ercüment, Karaman,Elanur, Yüce,Elif, Özdemir,Feyyaz
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista da Associação Médica Brasileira (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000801023
Resumo: SUMMARY OBJECTIVES: Black cumin is widely used as a spice and as a traditional treatment. The active ingredient in black cumin seeds is thymoquinone. Thymoquinone has shown anticancer effects in some cancers. We planned to investigate its anticancer effect on pancreatic cancer cell lines. METHODS: Thymoquinone chemical component in various doses was prepared and inoculated on pancreatic cancer cell culture, healthy mesenchymal stem cells, and peripheral blood mononuclear cell culture. IC50 values were calculated by absorbance data and measuring cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide staining of cells incubated with thymoquinone at 24, 48, and 72 h. RESULTS: There was dose-related cytotoxicity. Maximal cytotoxicity was observed at 24 h and 100 μM thymoquinone concentrations in pancreatic cancer cell culture and mesenchymal stem cells. Any concentration of thymoquinone was not cytotoxic to peripheral blood mononuclear cell. Thymoquinone even caused proliferation at a concentration of 6.25 μM. CONCLUSIONS: Since the cytotoxic concentration of thymoquinone on pancreatic cancer cell culture and mesenchymal stem cells is the same, it is not appropriate to use thymoquinone to achieve cytotoxicity in pancreatic cancer. However, since thymoquinone provides proliferation in peripheral blood mononuclear cell at a noncytotoxic dose, it may have an immune activator effect. Therefore, in vivo studies are needed to investigate the effect of thymoquinone on the immune system.
id AMB-1_707da8fb16ddddc4c1a53069c4bb9328
oai_identifier_str oai:scielo:S0104-42302022000801023
network_acronym_str AMB-1
network_name_str Revista da Associação Médica Brasileira (Online)
repository_id_str
spelling The effects of thymoquinone on pancreatic cancer and immune cellsCell survivalMesenchymal stem cellPancreatic cancerPeripheral Blood Mononuclear CellsThymoquinoneSUMMARY OBJECTIVES: Black cumin is widely used as a spice and as a traditional treatment. The active ingredient in black cumin seeds is thymoquinone. Thymoquinone has shown anticancer effects in some cancers. We planned to investigate its anticancer effect on pancreatic cancer cell lines. METHODS: Thymoquinone chemical component in various doses was prepared and inoculated on pancreatic cancer cell culture, healthy mesenchymal stem cells, and peripheral blood mononuclear cell culture. IC50 values were calculated by absorbance data and measuring cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide staining of cells incubated with thymoquinone at 24, 48, and 72 h. RESULTS: There was dose-related cytotoxicity. Maximal cytotoxicity was observed at 24 h and 100 μM thymoquinone concentrations in pancreatic cancer cell culture and mesenchymal stem cells. Any concentration of thymoquinone was not cytotoxic to peripheral blood mononuclear cell. Thymoquinone even caused proliferation at a concentration of 6.25 μM. CONCLUSIONS: Since the cytotoxic concentration of thymoquinone on pancreatic cancer cell culture and mesenchymal stem cells is the same, it is not appropriate to use thymoquinone to achieve cytotoxicity in pancreatic cancer. However, since thymoquinone provides proliferation in peripheral blood mononuclear cell at a noncytotoxic dose, it may have an immune activator effect. Therefore, in vivo studies are needed to investigate the effect of thymoquinone on the immune system.Associação Médica Brasileira2022-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000801023Revista da Associação Médica Brasileira v.68 n.8 2022reponame:Revista da Associação Médica Brasileira (Online)instname:Associação Médica Brasileira (AMB)instacron:AMB10.1590/1806-9282.20220066info:eu-repo/semantics/openAccessAlandağ,CelalKancaği,Derya DilekKarakuş Sir,GözdeÇakirsoy,DidemOvali,ErcümentKaraman,ElanurYüce,ElifÖzdemir,Feyyazeng2022-10-18T00:00:00Zoai:scielo:S0104-42302022000801023Revistahttps://ramb.amb.org.br/ultimas-edicoes/#https://old.scielo.br/oai/scielo-oai.php||ramb@amb.org.br1806-92820104-4230opendoar:2022-10-18T00:00Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)false
dc.title.none.fl_str_mv The effects of thymoquinone on pancreatic cancer and immune cells
title The effects of thymoquinone on pancreatic cancer and immune cells
spellingShingle The effects of thymoquinone on pancreatic cancer and immune cells
Alandağ,Celal
Cell survival
Mesenchymal stem cell
Pancreatic cancer
Peripheral Blood Mononuclear Cells
Thymoquinone
title_short The effects of thymoquinone on pancreatic cancer and immune cells
title_full The effects of thymoquinone on pancreatic cancer and immune cells
title_fullStr The effects of thymoquinone on pancreatic cancer and immune cells
title_full_unstemmed The effects of thymoquinone on pancreatic cancer and immune cells
title_sort The effects of thymoquinone on pancreatic cancer and immune cells
author Alandağ,Celal
author_facet Alandağ,Celal
Kancaği,Derya Dilek
Karakuş Sir,Gözde
Çakirsoy,Didem
Ovali,Ercüment
Karaman,Elanur
Yüce,Elif
Özdemir,Feyyaz
author_role author
author2 Kancaği,Derya Dilek
Karakuş Sir,Gözde
Çakirsoy,Didem
Ovali,Ercüment
Karaman,Elanur
Yüce,Elif
Özdemir,Feyyaz
author2_role author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Alandağ,Celal
Kancaği,Derya Dilek
Karakuş Sir,Gözde
Çakirsoy,Didem
Ovali,Ercüment
Karaman,Elanur
Yüce,Elif
Özdemir,Feyyaz
dc.subject.por.fl_str_mv Cell survival
Mesenchymal stem cell
Pancreatic cancer
Peripheral Blood Mononuclear Cells
Thymoquinone
topic Cell survival
Mesenchymal stem cell
Pancreatic cancer
Peripheral Blood Mononuclear Cells
Thymoquinone
description SUMMARY OBJECTIVES: Black cumin is widely used as a spice and as a traditional treatment. The active ingredient in black cumin seeds is thymoquinone. Thymoquinone has shown anticancer effects in some cancers. We planned to investigate its anticancer effect on pancreatic cancer cell lines. METHODS: Thymoquinone chemical component in various doses was prepared and inoculated on pancreatic cancer cell culture, healthy mesenchymal stem cells, and peripheral blood mononuclear cell culture. IC50 values were calculated by absorbance data and measuring cell viability by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide staining of cells incubated with thymoquinone at 24, 48, and 72 h. RESULTS: There was dose-related cytotoxicity. Maximal cytotoxicity was observed at 24 h and 100 μM thymoquinone concentrations in pancreatic cancer cell culture and mesenchymal stem cells. Any concentration of thymoquinone was not cytotoxic to peripheral blood mononuclear cell. Thymoquinone even caused proliferation at a concentration of 6.25 μM. CONCLUSIONS: Since the cytotoxic concentration of thymoquinone on pancreatic cancer cell culture and mesenchymal stem cells is the same, it is not appropriate to use thymoquinone to achieve cytotoxicity in pancreatic cancer. However, since thymoquinone provides proliferation in peripheral blood mononuclear cell at a noncytotoxic dose, it may have an immune activator effect. Therefore, in vivo studies are needed to investigate the effect of thymoquinone on the immune system.
publishDate 2022
dc.date.none.fl_str_mv 2022-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000801023
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-42302022000801023
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/1806-9282.20220066
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Médica Brasileira
publisher.none.fl_str_mv Associação Médica Brasileira
dc.source.none.fl_str_mv Revista da Associação Médica Brasileira v.68 n.8 2022
reponame:Revista da Associação Médica Brasileira (Online)
instname:Associação Médica Brasileira (AMB)
instacron:AMB
instname_str Associação Médica Brasileira (AMB)
instacron_str AMB
institution AMB
reponame_str Revista da Associação Médica Brasileira (Online)
collection Revista da Associação Médica Brasileira (Online)
repository.name.fl_str_mv Revista da Associação Médica Brasileira (Online) - Associação Médica Brasileira (AMB)
repository.mail.fl_str_mv ||ramb@amb.org.br
_version_ 1754212837808406528